These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Chemotherapy of recurrent medulloblastoma with combined procarbazine, CCNU, and vincristine. Crafts DC, Levin VA, Edwards MS, Pischer TL, Wilson CB. J Neurosurg; 1978 Oct; 49(4):589-92. PubMed ID: 690688 [Abstract] [Full Text] [Related]
6. PC or PCV, That Is the Question: Primary Anaplastic Oligodendroglial Tumors Treated with Procarbazine and CCNU With and Without Vincristine. Webre C, Shonka N, Smith L, Liu D, De Groot J. Anticancer Res; 2015 Oct; 35(10):5467-72. PubMed ID: 26408710 [Abstract] [Full Text] [Related]
7. Nitrosourea chemotherapy for primary malignant gliomas. Levin VA, Wilson CB. Cancer Treat Rep; 1976 Jun; 60(6):719-24. PubMed ID: 954010 [No Abstract] [Full Text] [Related]
8. Combination chemotherapy with CCNU, vincristine and methotrexate in primary and metastatic brain tumors. Hildebrand J, Brihaye J, Wagenknecht L, Michel J, Kenis Y. Eur J Cancer (1965); 1975 Aug; 11(8):585-7. PubMed ID: 1222765 [No Abstract] [Full Text] [Related]
9. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children. Levin VA, Lamborn K, Wara W, Davis R, Edwards M, Rabbitt J, Malec M, Prados MD. Neuro Oncol; 2000 Jan; 2(1):22-8. PubMed ID: 11302250 [Abstract] [Full Text] [Related]
10. Single-agent chemotherapy of brain tumors. A five-year review. Wilson CB, Gutin P, Boldrey EB, Drafts D, Levin VA, Enot KJ. Arch Neurol; 1976 Nov; 33(11):739-44. PubMed ID: 185991 [Abstract] [Full Text] [Related]
11. Procarbazine, CCNU and vincristine (PCV) combination chemotherapy for brain tumors. Brufman G, Halpern J, Sulkes A, Catane R, Biran S. Oncology; 1984 Nov; 41(4):239-41. PubMed ID: 6462602 [Abstract] [Full Text] [Related]
14. Radiotherapy combined with procarbazine, bleomycin, and CCNU in the treatment of high-grade supratentorial astrocytomas. Seiler RW, Greiner RH, Zimmerman A, Markwalder H. J Neurosurg; 1978 Jun; 48(6):861-5. PubMed ID: 77898 [Abstract] [Full Text] [Related]
16. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme. Levin VA, Uhm JH, Jaeckle KA, Choucair A, Flynn PJ, Yung WKA, Prados MD, Bruner JM, Chang SM, Kyritsis AP, Gleason MJ, Hess KR. Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233 [Abstract] [Full Text] [Related]
17. BCNU (NSC-409962) and procarbazine (NSC-77213) treatment for malignant brain tumors. Levin VA, Crafts DC, Wilson CB, Schultz MJ, Boldrey EB, Enot KJ, Pischer TL, Seager M, Elashoff RM. Cancer Treat Rep; 1976 Mar; 60(3):243-9. PubMed ID: 177210 [Abstract] [Full Text] [Related]
18. Procarbazine, lomustine and vincristine or temozolomide: which is the better regimen? Lassman AB. CNS Oncol; 2015 Mar; 4(5):341-6. PubMed ID: 26544062 [Abstract] [Full Text] [Related]
19. Dose-intensification of procarbazine, CCNU (lomustine), vincristine (PCV) with peripheral blood stem cell support in young patients with gliomas. Jakacki RI, Jamison C, Mathews VP, Heilman DK, Dropcho E, Cornetta K, Macdonald DR, Williams DA. Med Pediatr Oncol; 1998 Dec; 31(6):483-90. PubMed ID: 9835900 [Abstract] [Full Text] [Related]
20. A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma. Van Dyk JJ, Falkson G. Med Pediatr Oncol; 1975 Dec; 1(2):107-11. PubMed ID: 1228411 [Abstract] [Full Text] [Related] Page: [Next] [New Search]